Search filters

List of works by Javier de la Rubia

A phase II trial of lenalidomide, dexamethasone and cyclophosphamide for newly diagnosed patients with systemic immunoglobulin light chain amyloidosis.

scientific article published on 14 May 2015

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma

scientific article published on 08 July 2008

Activity and safety of lenalidomide and dexamethasone in patients with multiple myeloma requiring dialysis: a Spanish multicenter retrospective study.

scientific article published on 30 August 2010

Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors.

scientific article

Analysis of the immune system of multiple myeloma patients achieving long-term disease control by multidimensional flow cytometry.

scientific article

Anaphylactic shock and vitamin K1

scientific article published on 01 June 1989

Anemia hemolítica por anticuerpos del sistema ABO o Rh en pacientes receptores de trasplante de órgano sólido

scientific article published on 01 February 2003

Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis.

scientific article published on 10 April 2017

Autologous peripheral blood stem cell transplantation for acute leukaemias

scientific article published on 01 March 1999

Bendamustine, bortezomib and prednisone for the treatment of patients with newly diagnosed multiple myeloma: results of a prospective phase 2 Spanish/PETHEMA trial.

scientific article published on 24 April 2015

Benefit from autologous stem cell transplantation in primary refractory myeloma? Different outcomes in progressive versus stable disease

scientific article

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: results of a multicenter phase 1/2 study

scientific article published on 13 June 2006

Bortezomib plus melphalan and prednisone in elderly untreated patients with multiple myeloma: updated time-to-events results and prognostic factors for time to progression

scientific article published on 5 March 2008

Bortezomib-based induction therapy followed by intravenous busulfan-melphalan as conditioning regimen for patients with newly diagnosed multiple myeloma

scientific article published on 17 July 2014

CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors

article

CYP2C8 gene polymorphism and bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma

scientific article

Characteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation.

scientific article

Clinical treatment of newly diagnosed multiple myeloma

scientific article published on September 2015

Comment on "Outcomes of autologous transplantation for multiple myeloma according to different induction regimens".

scientific article published on March 2014

Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multiple Myeloma (short title)

scientific article

Cord blood transplantation from unrelated donors in adults with high-risk acute myeloid leukemia.

scientific article published on 8 September 2009

Current status of haematopoietic autologous stem cell transplantation in lymphoid malignancies: a European perspective.

scientific article published on 26 May 2014

DEPTOR expression and response to thalidomide: toward a new therapeutic target in multiple myeloma?

scientific article published on November 2010

Daratumumab monotherapy in patients with treatment-refractory multiple myeloma (SIRIUS): an open-label, randomised, phase 2 trial

scientific article published on 6 January 2016

Depth of Response in Multiple Myeloma: A Pooled Analysis of Three PETHEMA/GEM Clinical Trials

scientific article published on 12 May 2017

Diagnostic and therapeutic guidelines of thrombotic microangiopathies of the Spanish Apheresis Group

scientific article

Different patterns of relapse after autologous peripheral blood stem cell transplantation in multiple myeloma: clinical results of 280 cases from the Spanish Registry.

scientific article published in June 2002

Donor age-related differences in PBPC mobilization with rHuG-CSF.

scientific article published in February 2001

Eculizumab for the treatment of pregnancy-related atypical hemolytic uremic syndrome.

scientific article

Effect of CD8⁺ cell content on umbilical cord blood transplantation in adults with hematological malignancies

scientific article published on 05 July 2014

Effect of chemotherapy with alkylating agents on the yield of CD34+ cells in patients with multiple myeloma. Results of the Spanish Myeloma Group (GEM) Study

scientific article published on 19 April 2006

Efficacy and safety of rituximab in adult patients with idiopathic relapsing or refractory thrombotic thrombocytopenic purpura: results of a Spanish multicenter study

scientific article

European Perspective on Multiple Myeloma Treatment Strategies: Update Following Recent Congresses.

scientific article published in July 2012

European perspective on multiple myeloma treatment strategies in 2014

scientific article

European perspective on multiple myeloma treatment strategies: update following recent congresses

scientific article

FLAG-IDA regimen (fludarabine, cytarabine, idarubicin and G-CSF) in the treatment of patients with high-risk myeloid malignancies

scientific article published in August 2002

Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation.

scientific article

Filanesib in combination with pomalidomide and dexamethasone in refractory MM patients: safety and efficacy, and association with alpha 1-acid glycoprotein (AAG) levels. Phase Ib/II Pomdefil clinical trial conducted by the Spanish MM group

scientific article published on 05 June 2020

Flow cytometry for fast screening and automated risk assessment in systemic light-chain amyloidosis

scientific article published on 12 December 2018

Follow-up of healthy donors receiving granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization and collection. Results of the Spanish Donor Registry

scientific article published on 02 April 2008

Front-line lenalidomide therapy in patients with newly diagnosed multiple myeloma.

scientific article published on 10 April 2015

Further psychometric validation of the GAH scale: Responsiveness and effect size.

scientific article

Genetic Abnormalities and Patterns of Antigenic Expression in Multiple Myeloma

scientific article published on 01 May 2005

Genomic analysis of high-risk smoldering multiple myeloma.

scientific article published on 13 February 2012

High-risk cytogenetics and persistent minimal residual disease by multiparameter flow cytometry predict unsustained complete response after autologous stem cell transplantation in multiple myeloma

scientific article published on 29 November 2011

Imipenem/cilastatin with or without glycopeptide as initial antibiotic therapy for recipients of autologous stem cell transplantation: results of a Spanish multicenter study.

scientific article published on 12 February 2009

Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis.

scientific article published on 14 December 2015

Immunogenetic characterization of clonal plasma cells in systemic light-chain amyloidosis

scientific article published on 19 March 2020

Immunotherapy for the treatment of Hodgkin lymphoma.

scientific article published on 31 March 2017

Impact of the conditioning regimen in patients with multiple myeloma who undergo autologous transplantation

scientific article published on 11 April 2011

Impact on outcomes of human leukocyte antigen matching by allele-level typing in adults with acute myeloid leukemia undergoing umbilical cord blood transplantation

scientific article published on 01 January 2014

Incidence of Wra antigen and anti-Wra in a Spanish population

scientific article published on 01 August 2005

Incidence, risk factors, and outcome of cytomegalovirus infection and disease in patients receiving prophylaxis with oral valganciclovir or intravenous ganciclovir after umbilical cord blood transplantation

scientific article published on 11 April 2009

Infectious complications in patients with newly diagnosed multiple myeloma: A complication from the past?

scientific article published on October 2015

Influence of pre- and post-transplantation responses on outcome of patients with multiple myeloma: sequential improvement of response and achievement of complete response are associated with longer survival

scientific article

Intravenous busulfan and melphalan as a conditioning regimen for autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: a matched comparison to a melphalan-only approach.

scientific article

Intravenous busulfan plus melphalan versus melphalan alone as conditioning regimen for patients with multiple myeloma

scientific article published on 16 March 2019

Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.

scientific article published on September 2009

Lenalidomide and dexamethasone in transplant-ineligible patients with myeloma

scientific article published on September 2014

Lenalidomide plus dexamethasone for high-risk smoldering multiple myeloma

scientific article published in August 2013

Lenalidomide plus dexamethasone versus observation in patients with high-risk smouldering multiple myeloma (QuiRedex): long-term follow-up of a randomised, controlled, phase 3 trial.

scientific article published on 8 July 2016

Long-term prognostic significance of response in multiple myeloma after stem cell transplantation.

scientific article published on 11 April 2011

Methylene blue-photoinactivated plasma versus quarantine fresh frozen plasma in thrombotic thrombocytopenic purpura: a multicentric, prospective cohort study.

scientific article

Mild hemolytic disease of the newborn due to anit-Go(a)

scientific article published on 01 May 1999

Morbidity and transplant-related mortality of CBV and BEAM preparative regimens for patients with lymphoid malignancies undergoing autologous stem-cell transplantation

scientific article published on 01 August 2006

Multiparameter Flow Cytometry Evaluation of Plasma Cell DNA Content and Proliferation in 595 Transplant-Eligible Patients with Myeloma Included in the Spanish GEM2000 and GEM2005<65y Trials

article

Multiparameter flow cytometric remission is the most relevant prognostic factor for multiple myeloma patients who undergo autologous stem cell transplantation

scientific article published on 31 July 2008

Myeloablative treatments for multiple myeloma: update of a comparative study of different regimens used in patients from the Spanish registry for transplantation in multiple myeloma.

scientific article published in January 2002

Newly diagnosed versus relapsed idiopathic thrombotic thrombocytopenic purpura: a comparison of presenting clinical characteristics and response to treatment

scientific article

Panobinostat plus bortezomib and dexamethasone versus placebo plus bortezomib and dexamethasone in patients with relapsed or relapsed and refractory multiple myeloma: a multicentre, randomised, double-blind phase 3 trial

scientific article

Patterns of relapse and outcome of elderly multiple myeloma patients treated as front-line therapy with novel agents combinations

scientific article published on 24 September 2015

Pegfilgrastim as adjunct to chemotherapy to mobilize hematopoietic stem cells

scientific article published on 01 February 2005

Pembrolizumab as Consolidation Strategy in Patients with Multiple Myeloma: Results of the GEM-Pembresid Clinical Trial

scientific article published on 03 December 2020

Phase I/II study of weekly PM00104 (Zalypsis®) in patients with relapsed/refractory multiple myeloma.

scientific article

Phase II PETHEMA trial of alternating bortezomib and dexamethasone as induction regimen before autologous stem-cell transplantation in younger patients with multiple myeloma: efficacy and clinical implications of tumor response kinetics.

scientific article

Phase II clinical and pharmacokinetic study of plitidepsin 3-hour infusion every two weeks alone or with dexamethasone in relapsed and refractory multiple myeloma.

scientific article

Platelet transfusion and thrombotic thrombocytopenic purpura

scientific article published on 01 October 2002

Prediction of peripheral neuropathy in multiple myeloma patients receiving bortezomib and thalidomide: a genetic study based on a single nucleotide polymorphism array.

scientific article published on 8 September 2016

Prognostic Value of Immunophenotyping in Multiple Myeloma: A Study by the PETHEMA/GEM Cooperative Study Groups on Patients Uniformly Treated With High-Dose Therapy

scientific article published on 28 April 2008

Quality control of bacterial contamination in autologous peripheral blood stem cells for transplantation.

scientific article published on October 2004

Randomized phase 2 study: elotuzumab plus bortezomib/dexamethasone vs bortezomib/dexamethasone for relapsed/refractory MM.

scientific article published on 18 April 2016

Recent Advances in the Treatment of Patients with Multiple Myeloma

scientific article published on 30 November 2020

Recommendations on the clinical use of bendamustine in lymphoproliferative syndromes and multiple myeloma.

scientific article published on 14 July 2015

Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings

scientific article published on 01 July 2002

Role of autologous bone marrow transplant in multiple myeloma

scientific article published on November 1, 2012

Role of urine immunofixation in the complete response assessment of MM patients other than light-chain-only disease

scientific article published on 22 April 2019

Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields

scientific article published on 01 August 2002

Severe hemolytic anemia due to anti-E after renal transplantation

scientific article published on 01 August 1997

Severe hemolytic disease of the fetus due to anti-Jkb

scientific article published on 01 February 2008

Single daily dose of intravenous busulfan and melphalan as a conditioning regimen for patients with multiple myeloma undergoing autologous stem cell transplantation: a phase II trial.

scientific article published in February 2009

Single-agent daratumumab in patients with relapsed and refractory multiple myeloma requiring dialysis: results of a Spanish retrospective, multicentre study

scientific article published on 02 December 2019

Single-unit umbilical cord blood transplantation from unrelated donors in adult patients with chronic myelogenous leukemia.

scientific article published on 27 May 2010

Treatment of intra-abdominal bleeding with recombinant activated factor VII in a patient with disseminated intravascular coagulation secondary to septic shock

scientific article

Treatment of multiple myeloma in the elderly: realities and hopes

scientific article published on November 15, 2010

Tumor lysis syndrome in patients with acute myeloid leukemia: identification of risk factors and development of a predictive model

scientific article published in January 2008

Which therapies will move to the front line for multiple myeloma?

scientific article published on 07 April 2017

Zoledronic acid as compared with observation in multiple myeloma patients at biochemical relapse: results of the randomized AZABACHE Spanish trial

scientific article published on 11 June 2015

[Guidelines for the use of bisphosphonates in multiple myeloma: Recommendations of the expert committee of the Spanish Myeloma Group from the PETHEMA group]

scientific article published on 28 October 2009

[Thrombotic thrombocytopenic purpura]

scientific article published on 24 April 2010